Earnings History Data for Oncorus, Inc. (ONCR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Oncorus, Inc.
Oncorus Inc. is a clinical stage biopharmaceutical company. It is focused on developing viral immunotherapies to transform outcomes for cancer patients. The company's product candidate includes ONCR-177, which is in clinical stage. Oncorus Inc. is based in CAMBRIDGE, Mass.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
22-05-2023 | AH | ONCR | Oncorus | 8.00 | -1.18 | -0.70 | 0.00 | Oncorus GAAP EPS of -$1.18 misses by $0.48 [5/22/2023 4:53 PM] |
0.2594 | -0.06 (-17.52%) |
0.23 | -0.09 (-27.19%) |
0.21 - 1.90 | 508,705 | 50,000 | 298,849 | ||
24-03-2023 | PM | 7:00 AM ET (Mar 24) |
ONCR | Oncorus | 9.00 | -0.81 | -0.78 | 0.00 | Oncorus GAAP EPS of -$0.81 [3/24/2023 9:36 AM] |
0.3205 | 0.0 (0.12%) |
0.0 | 0.0 (0.00%) |
0.23 - 1.98 | 26,531 | 110,000 | 0 | |
04-08-2022 | PM | ONCR | Oncorus, Inc. | 34.94 | -0.74 | -0.74 | -0.60 | Oncorus GAAP EPS of -$0.74 misses by $0.02 [8/4/2022 8:40 AM] |
1.54 | 0.03 (1.99%) |
1.60 | 0.09 (5.96%) |
0.98 - 14.12 | 56,385 | 60,000 | 400 | ||
03-11-2021 | PM | ONCR | Oncorus | 289.00 | -0.65 | -0.65 | 0.00 | Oncorus EPS misses by $0.01 [11/3/2021 8:51 AM] |
11.23 | 0.40 (3.69%) |
0.0 | 0.0 (0.00%) |
8.75 - 37.86 | 75,040 | 90,000 | 0 | ||
04-08-2021 | PM | 7:00 AM ET (Aug 4) |
ONCR | Oncorus, Inc. | 328.53 | -0.60 | -0.58 | 0.00 | Oncorus EPS misses by $0.04 [8/4/2021 7:20 AM] |
12.02 | -0.41 (-3.30%) |
12.02 | 0.0 (0.00%) |
11.50 - 37.86 | 48,486 | 50,000 | 993 | |
04-05-2021 | PM | ONCR | Oncorus, Inc. | 412.00 | -0.53 | -0.54 | 0.00 | Oncorus EPS beats by $0.01 [5/4/2021 8:00 AM] |
14.99 | -1.04 (-6.49%) |
14.99 | 0.0 (0.00%) |
11.50 - 37.86 | 148,948 | 200,000 | 281,591 | ||
10-03-2021 | PM | ONCR | Oncorus, Inc. | 361.47 | -0.56 | -0.49 | 0.00 | Oncorus EPS misses by $0.08 [3/10/2021 7:54 AM] |
15.54 | 0.74 (5.00%) |
15.39 | 0.59 (3.99%) |
13.05 - 37.86 | 272,778 | 212,625 | 2,457 | ||